These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 17869100)

  • 1. Discovery, synthesis, and structure-activity studies of tetrazole based growth hormone secretagogues.
    Hernández AS; Cheng PT; Musial CM; Swartz SG; George RJ; Grover G; Slusarchyk D; Seethala RK; Smith M; Dickinson K; Giupponi L; Longhi DA; Flynn N; Murphy BJ; Gordon DA; Biller SA; Robl JA; Tino JA
    Bioorg Med Chem Lett; 2007 Nov; 17(21):5928-33. PubMed ID: 17869100
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimization of 1H-tetrazole-1-alkanenitriles as potent orally bioavailable growth hormone secretagogues.
    Hernández AS; Swartz SG; Slusarchyk D; Yan M; Seethala RK; Sleph P; Grover G; Dickinson K; Giupponi L; Harper TW; Humphreys WG; Longhi DA; Flynn N; Murphy BJ; Gordon DA; Biller SA; Robl JA; Tino JA
    Bioorg Med Chem Lett; 2008 Mar; 18(6):2067-72. PubMed ID: 18282707
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design and synthesis of tetrazole-based growth hormone secretagogue: the SAR studies of the O-benzyl serine side chain.
    Li J; Chen SY; Tao S; Wang H; Li JJ; Swartz S; Musial C; Hernandez AA; Flynn N; Murphy BJ; Beehler B; Dickinson KE; Giupponi L; Grover G; Seethala R; Sleph P; Slusarchyk D; Yan M; Humphreys WG; Zhang H; Ewing WR; Robl JA; Gordon D; Tino JA
    Bioorg Med Chem Lett; 2008 Mar; 18(6):1825-9. PubMed ID: 18295486
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery of a tetrazole-based growth hormone secretagogue: 4-(hydroxybutyl)carbamic acid 2-{5-[1-(2-amino-2-methylpropionylamino)-2- benzyloxyethyl]tetrazol-1-yl}ethyl ester (BMS-317180).
    Li J; Chen SY; Li JJ; Wang H; Hernandez AS; Tao S; Musial CM; Qu F; Swartz S; Chao ST; Flynn N; Murphy BJ; Slusarchyk DA; Seethala R; Yan M; Sleph P; Grover G; Smith MA; Beehler B; Giupponi L; Dickinson KE; Zhang H; Humphreys WG; Patel BP; Schwinden M; Stouch T; Cheng PT; Biller SA; Ewing WR; Gordon D; Robl JA; Tino JA
    J Med Chem; 2007 Nov; 50(24):5890-3. PubMed ID: 17973363
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tetrazole based amides as growth hormone secretagogues.
    Li JJ; Wang H; Li J; Qu F; Swartz SG; Hernández AS; Biller SA; Robl JA; Tino JA; Slusarchyk D; Seethala R; Sleph P; Yan M; Grover G; Flynn N; Murphy BJ; Gordon D
    Bioorg Med Chem Lett; 2008 Apr; 18(8):2536-9. PubMed ID: 18378446
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery and in vitro/in vivo studies of tetrazole derivatives as Kv1.5 blockers.
    Wu S; Fluxe A; Sheffer J; Janusz JM; Blass BE; White R; Jackson C; Hedges R; Murawsky M; Fang B; Fadayel GM; Hare M; Djandjighian L
    Bioorg Med Chem Lett; 2006 Dec; 16(24):6213-8. PubMed ID: 17010606
    [TBL] [Abstract][Full Text] [Related]  

  • 7. (D)-2-tert-Butoxycarbonylamino-5,5-difluoro-5-phenyl-pentanoic acid: synthesis and incorporation into the growth hormone secretagogues.
    Li J; Chen SY; Murphy BJ; Flynn N; Seethala R; Slusarchyk D; Yan M; Sleph P; Zhang H; Humphreys WG; Ewing WR; Robl JA; Gordon D; Tino JA
    Bioorg Med Chem Lett; 2008 Jul; 18(14):4072-4. PubMed ID: 18554903
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and SAR of amino acid-derived heterocyclic progesterone receptor full and partial agonists.
    Hammond M; Patterson JR; Manns S; Hoang TH; Washburn DG; Trizna W; Glace L; Grygielko ET; Nagilla R; Nord M; Fries HE; Minick DJ; Laping NJ; Bray JD; Thompson SK
    Bioorg Med Chem Lett; 2009 May; 19(10):2637-41. PubMed ID: 19376703
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Investigation on the role of the tetrazole in the binding of thiotetrazolylacetanilides with HIV-1 wild type and K103N/Y181C double mutant reverse transcriptases.
    Gagnon A; Landry S; Coulombe R; Jakalian A; Guse I; Thavonekham B; Bonneau PR; Yoakim C; Simoneau B
    Bioorg Med Chem Lett; 2009 Feb; 19(4):1199-205. PubMed ID: 19138518
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oxytocin analogues with amide groups substituted by tetrazole groups in position 4, 5 or 9.
    Manturewicz M; Grzonka Z; Borovicková L; Slaninová J
    Acta Biochim Pol; 2007; 54(4):805-11. PubMed ID: 18084651
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery of novel benzo[b]thiophene tetrazoles as non-carboxylate GPR40 agonists.
    Huang H; Winters MP; Meegalla SK; Arnoult E; Paul Lee S; Zhao S; Martin T; Rady B; Liu J; Towers M; Otieno M; Xu F; Lim HK; Silva J; Pocai A; Player MR
    Bioorg Med Chem Lett; 2018 Feb; 28(3):429-436. PubMed ID: 29258772
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bradykinin B1 receptor antagonists: an alpha-hydroxy amide with an improved metabolism profile.
    Kuduk SD; Chang RK; Dipardo RM; Di Marco CN; Murphy KL; Ransom RW; Reiss DR; Tang C; Prueksaritanont T; Pettibone DJ; Bock MG
    Bioorg Med Chem Lett; 2008 Sep; 18(18):5107-10. PubMed ID: 18722115
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure activity studies of the serine-AIB dipeptide domain in 2,3-dihydroisothiazole based growth hormone secretagogues.
    Evers B; Ruehter G; Berg M; Dodge JA; Hankotius D; Hary U; Jungheim LN; Mest HJ; de la Nava EM; Mohr M; Muehl BS; Petersen S; Sommer B; Riedel-Herold G; Tebbe MJ; Thrasher KJ; Voelkers S
    Bioorg Med Chem; 2005 Dec; 13(24):6748-62. PubMed ID: 16219466
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Toward potent ghrelin receptor ligands based on trisubstituted 1,2,4-triazole structure. 2. Synthesis and pharmacological in vitro and in vivo evaluations.
    Moulin A; Demange L; Bergé G; Gagne D; Ryan J; Mousseaux D; Heitz A; Perrissoud D; Locatelli V; Torsello A; Galleyrand JC; Fehrentz JA; Martinez J
    J Med Chem; 2007 Nov; 50(23):5790-806. PubMed ID: 17927165
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure-based prediction of Mycobacterium tuberculosis shikimate kinase inhibitors by high-throughput virtual screening.
    Segura-Cabrera A; Rodríguez-Pérez MA
    Bioorg Med Chem Lett; 2008 Jun; 18(11):3152-7. PubMed ID: 18486472
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tetrazole hybrids with potential anticancer activity.
    Zhang J; Wang S; Ba Y; Xu Z
    Eur J Med Chem; 2019 Sep; 178():341-351. PubMed ID: 31200236
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Highly potent growth hormone secretagogues.
    Lu Z; Tata JR; Cheng K; Wei L; Chan WW; Butler B; Schleim KD; Jacks TM; Hickey G; Patchett AA
    Bioorg Med Chem Lett; 2007 Jul; 17(13):3657-9. PubMed ID: 17482461
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Allosteric potentiators of the metabotropic glutamate receptor 2 (mGlu2). Part 1: Identification and synthesis of phenyl-tetrazolyl acetophenones.
    Pinkerton AB; Cube RV; Hutchinson JH; Rowe BA; Schaffhauser H; Zhao X; Daggett LP; Vernier JM
    Bioorg Med Chem Lett; 2004 Nov; 14(21):5329-32. PubMed ID: 15454221
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery of substituted benzyl tetrazoles as histamine H3 receptor antagonists.
    Davenport AJ; Stimson CC; Corsi M; Vaidya D; Glenn E; Jones TD; Bailey S; Gemkow MJ; Fritz U; Hallett DJ
    Bioorg Med Chem Lett; 2010 Sep; 20(17):5165-9. PubMed ID: 20667729
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Process research and development for a tetrazole-based growth hormone secretagogue (GHS) pharmaceutical development candidate.
    Davulcu AH; McLeod DD; Li J; Katipally K; Littke A; Doubleday W; Xu Z; McConlogue CW; Lai CJ; Gleeson M; Schwinden M; Parsons RL
    J Org Chem; 2009 Jun; 74(11):4068-79. PubMed ID: 19391593
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.